Latest Convertible Debt News

Thrive Tribe Technologies has raised approximately $250,000 through a discounted share placement and repaid nearly $100,000 in loans by issuing shares, aiming to bolster working capital.

Eden Innovations Ltd has announced a non-renounceable entitlement offer to raise approximately $5.7 million, issuing new shares at $0.035 each alongside free options exercisable at $0.07. The capital raise aims to support business expansion and debt reduction.

Tartana Minerals has secured an additional $0.5 million in non-dilutive financing with plans to refinance into convertible notes, pending shareholder approval at the upcoming AGM.

Life360, Inc. reported a return to profitability in Q2 2025, driven by strong subscription growth and strategic partnerships, while also announcing a leadership transition and issuing $320 million in convertible notes.

RBR Group Limited is strategically positioning itself to capitalise on the restart of major LNG projects in Mozambique, advancing joint ventures and raising capital to meet anticipated demand.

Doctor Care Anywhere has reported a landmark positive operating and investing cash inflow in Q2 2025, alongside modest consultation growth and strategic service expansion. The company reiterates its ambitious revenue and profitability targets amid ongoing cost transformation.

GBM Resources has raised $13 million through a two-tranche placement, repaid $6.2 million in convertible debt, and completed a significant board restructure to accelerate exploration at its Drummond Basin gold projects.

Horizon Minerals reported a solid cash position of A$15.7 million at the end of June 2025, supported by a US$5 million convertible loan facility, providing a runway of approximately 6.5 quarters at current spending levels.

Locate Technologies Limited reported a significant cash burn in its latest quarterly cash flow report, highlighting ongoing operational and investing outflows amid stable financing arrangements.

Immutep Limited advances its pivotal Phase III lung cancer trial and reports promising results across multiple oncology and autoimmune programs, supported by a solid cash position to fund operations through 2026.

Rewardle Holdings Limited remains suspended from ASX trading due to prolonged delays in lodging financial reports, with the exchange warning of imminent delisting unless compliance is demonstrated by mid-September.

Mantle Minerals has received conversion notices for over half of its outstanding convertible notes, prompting a shareholder vote in September to decide on converting $742,000 of debt into shares with attached options.